Who owns Viridian Therapeutics, Inc.?
Institutional ownership of VRDN from SEC Form 13F filings across 138 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
138
13F holders
$1.24B
value, 2026 filers
64.7%
of shares outstanding (73.3M sh)
29
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of VRDN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 16.6M | $305.0M | 0.0% | 14.7% | +8.0% |
| 2 | BlackRock, Inc. | 8.6M | $157.1M | 0.0% | 7.5% | +9.2% |
| 3 | PRICE T ROWE ASSOCIATES INC /MD/ | 5.7M | $105,599 | 0.0% | 5.1% | +79.3% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.6M | $84.1M | 0.0% | 4% | -45.1% |
| 5 | WELLINGTON MANAGEMENT GROUP LLP | 3.1M | $57.5M | 0.0% | 2.8% | +1.6% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.8M | $50.6M | 0.0% | 2.4% | +67.7% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.5M | $46.0M | 0.0% | 2.2% | +7.2% |
| 8 | Point72 Asset Management, L.P. | 2.3M | $43.0M | 0.0% | 2.1% | +625.8% |
| 9 | Fisher Asset Management, LLC | 1.8M | $32.2M | 0.0% | 1.5% | -1.0% |
| 10 | Candriam S.C.A. | 1.7M | $31.3M | 0.1% | 1.5% | +139.9% |
| 11 | GOLDMAN SACHS GROUP INC | 1.7M | $31.1M | 0.0% | 1.5% | +6.2% |
| 12 | UBS Group AG | 1.4M | $26.2M | 0.0% | 1.3% | +365.2% |
| 13 | ALLIANCEBERNSTEIN L.P. | 1.4M | $27.2M | 0.0% | 1.2% | 0.0% |
| 14 | Balyasny Asset Management L.P. | 1.3M | $23.5M | 0.0% | 1.1% | -44.7% |
| 15 | D. E. Shaw & Co., Inc. | 1.2M | $21.7M | 0.0% | 1% | -6.4% |
| 16 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.1M | $20.4M | 0.0% | 1% | +4678.6% |
| 17 | BNP PARIBAS FINANCIAL MARKETS | 1.0M | $18.6M | 0.0% | 0.9% | +279.9% |
| 18 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 999,915 | $18.4M | 0.0% | 0.9% | +12.6% |
| 19 | BANK OF AMERICA CORP /DE/ | 944,345 | $17.3M | 0.0% | 0.8% | -18.8% |
| 20 | NORTHERN TRUST CORP | 863,491 | $15.9M | 0.0% | 0.8% | +23.9% |
| 21 | Sixth Street Partners Management Company, L.P.NEW | 815,027 | $15.0M | 2.6% | 0.7% | new |
| 22 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 815,027 | $15.0M | 0.0% | 0.7% | +12.0% |
| 23 | Schonfeld Strategic Advisors LLCNEW | 793,508 | $14.6M | 0.1% | 0.7% | new |
| 24 | MORGAN STANLEY | 728,817 | $13.4M | 0.0% | 0.6% | -16.2% |
| 25 | Woodline Partners LP | 700,929 | $12.9M | 0.0% | 0.6% | -50.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.